News

Life Sciences M&A Values Soar in 2011 May 14, 2012 | Press Release

Life Sciences M&A Activity Heats Up in April, says Burrill & Company May 01, 2012 | Press Release

Burrill & Company Leads $12.9 Million Series E Round In WhiteGlove Health April 16, 2012 | Press Release

  See all News
 
Sign up for a free subscription to The Burrill Weekly Brief 
Sign up to receive email notifications about our upcoming events and news.


Small Company Biotech 2010-Life Sciences: Adapting for Success Enterprise License


  

Charles Darwin told us that it is not the strongest of the species that survives, nor the most intelligent, but the one most responsive to change. Biotech 2010—Life Sciences: Adapting for Success, Burrill & Company’s latest annual report on the industry, provides insight into biotech’s changing environment and how not to just survive but succeed.

 
Learn how to thrive
Available in March 2010, the publication provides thoughtful information and analysis on how companies need to adapt to major challenges to their business development in order to be successful in 2010 and beyond. These include: raising capital, impending healthcare reform, comparative effectiveness research, generics, biosimilars, reimbursement pressures and regulatory changes.
 
In addition Biotech 2010 presents:

• Comprehensive 2009 industry financials, private and public capital raised, M&A/Partnering activity of life sciences companies operating in the United States, Europe, Canada, and Asia.
 
• Analysis on key developments in healthcare, personalized medicine, biogreentech, emerging technologies, politics and policy and globalization…and much more.

Click here to view the Table of Contents.

THIS IS FOR A PDF VERSION OF BIOTECH 2010-LIFE SCIENCES: ADAPTING FOR SUCCESS AND THE RIGHT FOR A SMALL COMPANY (UP TO 50 EMPLOYEES) TO POST ON ITS CORPORATE INTRATNET FOR EMPLOYEES ONLY.



Add to cart$1,000.00